Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guilin Zhongzu Chinese Medicine Co., Ltd. (formerly Guilin Yongfu Pharmaceutical Factory) is a Chinese pharmaceutical company founded in 1974 and headquartered in Guilin, Guangxi. The company specializes in the research, development, manufacturing, and sales of traditional Chinese patent medicines (TCM) and herbal extracts, particularly leveraging local Grosvenor Momordica (Luo Han Guo) resources. Its product portfolio spans seven major dosage forms, including granules, tablets, capsules, tinctures, powders, syrups, and beverages, with over 60 products. Key commercial products include Luo Han Guo Cough Granules, Shanlücha Antihypertensive Tablets, Motherwort (Yimucao) Granules, and Banlangen Granules, which are distributed domestically and exported to Southeast Asia, Europe, and North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guilin Zhongzu Chinese Medicine.